FK 706

FK 706 Suppliers list
Company Name: Sichuan Wei Keqi Biological Technology Co., Ltd.  
Tel: 028-81700200 18116577057
Email: 3003855609@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com

FK 706 manufacturers

  • FK706
  • FK706 pictures
  • $3190.00
  • 2026-07-27
  • CAS:144055-55-0
  • Purity:
  • Supply Ability: 10g
FK 706 Basic information
Product Name:FK 706
Synonyms:FK 706;FK-706,FK706;Sodium 2-[[4-[[(2S)-3-methyl-1-oxo-1-[(2S)-2-[(1,1,1-trifluoro-4-methyl-2-oxopentan-3-yl)carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbam oyl]benzoyl]amino]acetic acid
CAS:144055-55-0
MF:C26H34F3N4NaO7
MW:594.56
EINECS:
Product Categories:
Mol File:144055-55-0.mol
FK 706 Structure
FK 706 Chemical Properties
storage temp. 4°C, protect from light
solubility DMSO: 115 mg/mL (194.08 mM)
form Solid
color White to off-white
Cosmetics Ingredients FunctionsSKIN CONDITIONING
Safety Information
MSDS Information
FK 706 Usage And Synthesis
UsesFK706 is a potent, slow-binding and competitive inhibitor of human neutrophil elastase with an IC50 of 83 nM and a Ki of 4.2 nM. FK706 also inhibits mouse neutrophil elastase and porcine pancreatic elastase with IC50s of 22 nM and 100 nM, respectively, and has no inhibitory activity against other serine proteinases such as human pancreatic trypsin, human pancreatic α-chymotrypsin and human leukocyte cathepsin G. FK706 has anti-inflammatory effect[1][2].
in vivo

FK706 (10-100 mg/kg; subcutaneous injection; for 1-6 hours; male C57BL mice) treatment significantly suppresses human neutrophil elastase (20 μg/paw)-induced paw edema in mice in a dose-dependent manner (47% inhibition at a dose of 100 mg/kg)[1].

Animal Model:Male C57BL mice (6 weeks old) injected with human neutrophil elastase[1]
Dosage:10 mg/kg, 32 mg/kg, 100 mg/kg
Administration:Subcutaneous injection; for 1 hour, 2 hours, 4 hours, 6 hours
Result:Significantly suppressed human neutrophil elastase-induced paw edema in mice in a dose-dependent manner.
References[1] Shinguh Y, et al. Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor. Eur J Pharmacol. 1997 Oct 15;337(1):63-71. DOI:10.1016/s0014-2999(97)01284-3
[2] Numanami H, et al. Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts. Am J Respir Cell Mol Biol. 2003 Nov;29(5):613-9. DOI:10.1165/rcmb.2003-0113OC
FK 706 Preparation Products And Raw materials
Tag:FK 706(144055-55-0) Related Product Information
MDL 101146 N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide (R)- (S)- FK 706 AZD 9668